who is eligible for glp 1 π’ Two important dates patients interested in GLP-1 medications: β July 1, 2026 β Medicare GLP-1 Bridge Program begins for Medicare Part D beneficiaries. β October 1, 2026 β Zepbound What BMI Do You Need
Description
Taken together, the Magruder et al
Ive never had this much confidence before in my life! We didnt want to wait for health issues to hitwe wanted to take control early
74 SURPASS-6 (A study of tirzepatide (LY3298176) versus insulin lispro (U100) in participants with type 2 diabetes inadequately controlled on insulin glargine (U100) with or without metformin
The replacement of GLP-1 (737) Lys 34 with Arg causes a two-fold reduction in the EC 50
Patients with statin intolerance should first consider evidence-based alternatives like ezetimibe, bempedoic acid, PCSK9 inhibitors, or inclisiran before considering GLP-1 therapy primarily for lipid management
